SCHEMBL7676953

SCHEMBL7676953

CCN(CC)CCCN(c1ccc2c(c1)nc(CCc1ccc(N)cc1)n2C)S(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
GAA P10253 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
F2 P00734 6/20 0.47
PKM P14618 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HDAC1 Q13547 3/20 0.39
HDAC8 Q9BY41 3/20 0.39
HDAC3 O15379 1/20 0.39
PTGS1 P23219 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
NR1I2 O75469 2/20 0.39
MEN1 O00255 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979801 0.90 F2 (0.62) F2PKMALDH1A1
Hydrochloric Acid SCHEMBL7400466 0.87 F2 (0.47) NPC1GAARAB9ASMN1; SMN2F2
SCHEMBL6983757 0.84 F2 (0.63) F2PKMALDH1A1
SCHEMBL6980944 0.84 F2 (0.44) NPC1GAARAB9ASMN1; SMN2F2
Hydrochloric Acid SCHEMBL6986105 0.84 F2 (0.62) F2PKMALDH1A1
Hydrochloric Acid SCHEMBL6969834 0.83 F2 (0.54) NPC1GAARAB9ASMN1; SMN2F2
Hydrochloric Acid SCHEMBL6966635 0.80 F2 (0.55) NPC1GAARAB9ASMN1; SMN2F2
SCHEMBL6985103 0.79 F2 (0.66) F2HDAC1MEN1RECQLKMT2A
SCHEMBL7672690 0.79 F2 (0.48) GAAF2PKMALDH1A1HDAC1
SCHEMBL7664576 0.78 F2 (0.61) F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365584-B1 FOR PROPHYLAXIS AND THERAPY OF INFLAMMATORY AND/OR ALLERGIC DISEASES, LUNG FIBROSIS, FIBROSING ALVEOLITIS AND SCARRING, COLLAGENOSES SUCH AS LUPUS ERYTHEMATODES AND SCLERODERMIA AS WELL AS ARTERIOSCLEROSIS, PSORIASIS AND NEOPLASM BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-04-02 US disclosed